PRS
ECYT

Pinkerton Retirement Specialists’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Pinkerton Retirement Specialists’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-28
Closed – – 582
2016
Q4 		$0 Hold
28
– – ﹤0.01% 670
2016
Q3 		$0 Hold
28
– – ﹤0.01% 683
2016
Q2 		$0 Buy
+28
New +$103 ﹤0.01% 674

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Pinkerton Retirement Specialists's ECYT Position: Q1 2017 in Review

Pinkerton Retirement Specialists sold out of Endocyte, Inc. Common Stock (ECYT) in Q1 2017, closing a stake of 28 shares.

Pinkerton Retirement Specialists first reported a position in ECYT in Q2 2016 and held it in 3 quarters. The position peaked at $0 in Q4 2016. 82 funds tracked by Wall St. Rank hold ECYT as of Q1 2017.

  • Pinkerton Retirement Specialists reported no remaining Endocyte, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Pinkerton Retirement Specialists sold 28 Endocyte, Inc. Common Stock shares in Q1 2017.
  • Pinkerton Retirement Specialists first reported a position in Endocyte, Inc. Common Stock in Q2 2016 and held it in 3 quarters.
  • Pinkerton Retirement Specialists's Endocyte, Inc. Common Stock position peaked at $0 in Q4 2016.
  • 82 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q1 2017.

Based on Pinkerton Retirement Specialists's 13F filing for Q1 2017, filed 15 May 2017.